<DOC>
	<DOCNO>NCT00006134</DOCNO>
	<brief_summary>OBJECTIVES : I . Continue yearly ascertainment visit patient establish Lupus Minority Populations : Nature v Nurture ( LUMINA ) study cohort . II . Recruit LUMINA cohort newly diagnose patient systemic lupus erythematosus ( SLE ) . III . Determine impact additional major histocompatibility complex ( MHC ) non-MHC genetic factor previously examine , specifically tumor necrosis factor , mannose bind protein , interleukin-1 receptor antagonist , bcl-2 , course outcome SLE . IV . Refine assessment clinical behavioral-cultural factor find important predictor disease activity , damage , functioning , thus far patient . V. Determine relationships among disease activity , disease damage , physical mental functioning patient SLE progress factor predict .</brief_summary>
	<brief_title>Study Predictors Course Early Outcome Patients With Systemic Lupus Erythematosus : Nature Versus Nurture</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This parallel , follow study natural history study . Patients stratify accord ethnicity ( Caucasian v African-American v Hispanic ) . Patients examine baseline every 6 month thereafter order determine relative impact genetic , sociodemographic , behavioral-cultural factor disease outcome . Patients assess follow outcome variable : disease activity Systemic Lupus Activity Measure ( SLAM ) , disease damage Systemic Lupus International Collaborative Clinics Damage Index ( SDI ) , physical mental function Medical Outcomes Study 36 Item Short-Form Health Survey ( SF-36 ) . Patients also assess independent variable belong follow domain : socioeconomic-demographic , clinical , immunogenetic , behavioral-cultural . Patients undergo genetic analysis utilizing polymerase chain reaction electrophoresis study immunogenetic domain genetic marker may relate disease . Specifically , patient ' blood analyze tumor necrosis factor alpha , tumor necrosis factor beta , mannose bind protein , interleukin-1 receptor antagonist , bcl-2 .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>All systemic lupus erythematosus ( SLE ) patient currently constitute establish Lupus Minority Populations : Nature v Nurture ( LUMINA ) cohort OR New recruit meet least 4 1997 American College Rheumatology criterion classification SLE Disease onset within past 5 year AfricanAmerican , Hispanic , Caucasian Self state , plus 4 grandparent No concurrent participation intervention study Not pregnant Not mentally retarded No prisoner No concurrent disability would preclude study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>arthritis &amp; connective tissue disease</keyword>
	<keyword>immunologic disorder infectious disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>systemic lupus erythematosus</keyword>
</DOC>